Axsome Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Hot FDA News Momentum Movers

Axsome Therapeutics (AXSM) Rallies After Auvelity Gains FDA ApprovalAugust 19, 2022 2:13 PM Cowen Reiterates Outperform, $130 PT on Axsome Therapeutics (AXSM) Following FDA ApprovalAugust 19, 2022 10:39 AM Axsome Therapeutics (AXSM) Announces FDA Approval of AUVELITYAugust 19, 2022 6:46 AM Axsome Therapeutics Announces FDA Approval of AUVELITY™, the First and Only Oral NMDA Receptor Antagonist for the Treatment of Major Depressive Disorder in AdultsAugust 19, 2022 6:46 AM